U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. XEMBIFY
  1. Vaccines, Blood & Biologics

BL: 125683
Proper Name: XEMBIFY
Tradename: Immune Globulin Subcutaneous, Human - klhw, 20%
Manufacturer: Grifols Therapeutics LLC
Indication:

  • For subcutaneous injection indicated for treatment of Primary Humoral Immunodeficiency (PI) in patients 2 years of age and older.

Product Information

Supporting Documents

Back to Top